Font: Financial Modeling Prep • Aug 27, 2026
NVIDIA (NASDAQ: NVDA) is a prominent chipmaker at the forefront of the artificial intelligence boom. The company designs graphics processing units (GPUs) that are critical for running complex AI models. With a market capitalization of approximately $5.08 trillion, it stands as one of the largest and most influential companies in the technology sector.
On August 27, 2026, an analyst from Bernstein raised their price target for NVIDIA to $400.00. At the time, the stock was trading at $209.66, which represents a potential upside of approximately 90.79% to the new target. This indicates a very optimistic view of the company's future stock performance.
This positive outlook is backed by the company's strong financial forecasts. NVIDIA projects its revenue will grow by approximately 70% in fiscal 2028. As highlighted by Bloomberg Markets and Finance, this figure is significantly higher than the 45% growth that analysts had previously anticipated, underscoring robust business expansion.
The market is responding well to NVIDIA's performance. Following a blockbuster earnings report, NVIDIA's stock saw a 6% increase in premarket trading, as highlighted by CNBC. This news has bolstered confidence not just in the company but in the entire artificial intelligence sector.
Further fueling this momentum, NVIDIA is reportedly set to acquire Hugging Face for approximately $12.9 billion, as reported by The Information. While neither company has commented, such a move would significantly strengthen NVIDIA's position in the AI industry by integrating a leading AI platform.
|
VNRX§>
VolitionRX Ltd
|
$0.50
47.70%
|
|
NVDA§>
NVIDIA Corporation
|
$227.98
8.74%
|
|
RITR§>
Reitar Logtech Holdings Limited Ordinary shares
|
$0.10
11.75%
|
|
CELU§>
Celularity Inc.
|
$2.10
138.53%
|
|
NVD§>
GraniteShares 2x Short NVDA Daily ETF
|
$3.73
-16.93%
|
|
WKSP§>
Worksport Ltd.
|
$0.63
23.53%
|
|
MERC§>
Mercer International Inc.
|
$0.39
-5.57%
|
|
INTC§>
Intel Corp.
|
$92.09
4.36%
|
|
NCPL§>
Netcapital Inc.
|
$0.54
7.55%
|
|
PPCB§>
Propanc Biopharma, Inc.
|
$2.23
108.41%
|